Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1029)	6/13/2005 10:13:17 PM
From: Galirayo	Read Replies (1) \| Respond to of 3722

[VICL] Looked nasty most of the day .. it was a late in the day turn .. I was looking for a reasonable Bottom for it and it seemed to find it late in the day. I was on the verge of turning it loose till it found one .. Glad I waited. Ray

To: Jibacoa who wrote (1029)	6/29/2005 4:29:23 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

VICL Continued the uptrend that started on June 13 and is ready to test its March Hs The stock was up another 8.49% today on volume of 239,270 On June 22 it went through the previously mentioned resistance at 4 and yesterday it went through its new resistance at 4.15 <g> bigcharts.marketwatch.com On its longer term chart, VICL still seems to have "potential".<g> bigcharts.marketwatch.com So far this month it has had several positive announcements, including: A $12M order for its DNA vaccines against HIV from the VRC at NIAID; The FDA designating its CMV Vaccine an "orphan drug" And granting MRK the use of VICL technology in cancer vaccine applications, whuch should provide VICL with some $3M and possible milestone and royalty payments. Bernard